What's New in Regulatory Science
A newsletter on regulatory science for CDER's stakeholders
Several times a year the Center for Drug Evaluation and Research sends out an update to share information on new developments, opportunities, and initiatives in regulatory science with the goal of advancing medical product development.
2023
- Issue I, 2023 (PDF - 638 KB)
- Issue II, 2023 (PDF - 701 KB)
- Issue III, 2023 (PDF - 435 KB)
2022
- Spring 2022 (PDF - 782 KB)
- Fall 2022 (PDF - 554 KB)
- Winter 2022 (PDF - 570 KB)
2021
- Spring 2021 (PDF - 628 KB)
- Summer 2021 (PDF - 653 KB)
- Fall 2021 (PDF - 601 KB)
2020
- Spring 2020 (PDF - 641 KB)
- Summer 2020 (PDF - 444 KB)
- Fall 2020 (PDF - 524 KB)
2019
- Winter 2019 (PDF - 703 KB)
- Summer 2019 (PDF - 444 KB)
- Fall 2019 (PDF - 541 KB)
2018
- Winter 2018 (PDF - 703 KB)
- Summer/Fall 2018 (PDF - 437 KB)
2017
- Winter 2017 (PDF - 1 MB)
- Spring/Summer 2017 (PDF - 1 MB)
- Fall 2017 (PDF - 811 KB)
If you have comments or questions, contact the CDER Office of Translational Sciences at OTSCommunications@fda.hhs.gov.